Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Total Non-Current Liabilities: 2009-2012

Historic Total Non-Current Liabilities for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $74.0 million.

  • Lexicon Pharmaceuticals' Total Non-Current Liabilities rose 3.35% to $74.0 million in Q3 2012 from the same period last year, while for Sep 2012 it was $74.0 million, marking a year-over-year increase of 3.35%. This contributed to the annual value of $77.8 million for FY2011, which is 9.46% up from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Total Non-Current Liabilities stood at $74.0 million for Q3 2012, which was down 3.77% from $76.9 million recorded in Q2 2012.
  • Lexicon Pharmaceuticals' 5-year Total Non-Current Liabilities high stood at $93.6 million for Q4 2009, and its period low was $54.8 million during Q3 2010.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Total Non-Current Liabilities value was $74.0 million (recorded in 2012), while the average stood at $73.4 million.
  • In the last 5 years, Lexicon Pharmaceuticals' Total Non-Current Liabilities slumped by 41.16% in 2010 and then skyrocketed by 30.64% in 2011.
  • Over the past 4 years, Lexicon Pharmaceuticals' Total Non-Current Liabilities (Quarterly) stood at $93.6 million in 2009, then dropped by 24.10% to $71.1 million in 2010, then grew by 9.46% to $77.8 million in 2011, then grew by 3.35% to $74.0 million in 2012.
  • Its last three reported values are $74.0 million in Q3 2012, $76.9 million for Q2 2012, and $76.7 million during Q1 2012.